doi: 10.1161/CIRCULATIONAHA.106.646091
(Circulation. 2007;115:584-592.)
© 2007 American Heart Association, Inc.
Heart Failure |
Critical Role of Monocyte Chemoattractant Protein-1/CC Chemokine Ligand 2 in the Pathogenesis of Ischemic Cardiomyopathy
From the Section of Cardiovascular Sciences and DeBakey Heart Center, the Methodist Hospital, Baylor College of Medicine (N.G.F., O.D., Y.X., G.R., S.H., T.L., D.K., G.T., M.L.E.), Houston, Tex; Department of Cardiac Surgery, University of Bonn (O.D.), Bonn, Germany; and Department of Medical Oncology, Dana-Farber Cancer Institute (B.J.R.), Harvard Medical School, Boston, Mass.
Correspondence to Nikolaos G. Frangogiannis, MD, Section of Cardiovascular Sciences, One Baylor Plaza M/S F-602, Baylor College of Medicine, Houston, TX 77030. E-mail ngf{at}bcm.tmc.edu
Received June 15, 2006; accepted November 13, 2006.
Background— Cardiac interstitial fibrosis plays an important role in the pathogenesis of ischemic cardiomyopathy, contributing to systolic and diastolic dysfunction. We have recently developed a mouse model of fibrotic noninfarctive cardiomyopathy due to brief repetitive myocardial ischemia and reperfusion. In this model, fibrotic changes are preceded by marked and selective induction of the CC chemokine monocyte chemoattractant protein-1 (MCP-1). We hypothesized that MCP-1 may mediate fibrotic remodeling through recruitment of mononuclear cells and direct effects on fibroblasts.
Methods and Results— Wild-type (WT) and MCP-1-null mice underwent daily 15-minute coronary occlusions followed by reperfusion. Additional WT animals received intraperitoneal injections of a neutralizing anti-MCP-1 antibody after the end of each ischemic episode. Hearts were examined echocardiographically and processed for histological and RNA studies. WT mice undergoing repetitive brief myocardial ischemia and reperfusion protocols exhibited macrophage infiltration after 3 to 5 days and marked interstitial fibrosis in the ischemic area after 7 days, accompanied by ventricular dysfunction. MCP-1-null mice had markedly diminished interstitial fibrosis, lower macrophage infiltration, and attenuated ventricular dysfunction compared with WT animals. MCP-1 neutralization also inhibited interstitial fibrosis, decreasing left ventricular dysfunction and regional hypocontractility. Cardiac myofibroblasts isolated from WT but not from MCP-1-null animals undergoing repetitive myocardial ischemia and reperfusion demonstrated enhanced proliferative capacity. However, MCP-1 stimulation did not induce cardiac myofibroblast proliferation and did not alter expression of fibrosis-associated genes.
Conclusions— Defective MCP-1 signaling inhibits the development of ischemic fibrotic cardiomyopathy in mice. The profibrotic actions of MCP-1 are associated with decreased macrophage recruitment and may not involve direct effects on cardiac fibroblasts.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  S. L. Lin, A. P. Castano, B. T. Nowlin, M. L. Lupher Jr., and J. S. Duffield Bone Marrow Ly6Chigh Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations J. Immunol., November 15, 2009; 183(10): 6733 - 6743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Blyszczuk, G. Kania, T. Dieterle, R. R. Marty, A. Valaperti, C. Berthonneche, T. Pedrazzini, C. T. Berger, S. Dirnhofer, C. M. Matter, et al. Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy Circ. Res., October 23, 2009; 105(9): 912 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Haudek, D. Gupta, O. Dewald, R. J. Schwartz, L. Wei, J. Trial, and M. L. Entman Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation Cardiovasc Res, August 1, 2009; 83(3): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Defer, J. Wan, R. Souktani, B. Escoubet, M. Perier, P. Caramelle, S. Manin, V. Deveaux, M.-C. Bourin, A. Zimmer, et al. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J, July 1, 2009; 23(7): 2120 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Keeley, B. Mehrad, and R. M. Strieter Chemokines as Mediators of Neovascularization Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1928 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Haudek, J. Trial, Y. Xia, D. Gupta, D. Pilling, and M. L. Entman Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells PNAS, July 22, 2008; 105(29): 10179 - 10184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bujak, M. Dobaczewski, K. Chatila, L. H. Mendoza, N. Li, A. Reddy, and N. G. Frangogiannis Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling Am. J. Pathol., July 1, 2008; 173(1): 57 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bujak, H. J. Kweon, K. Chatila, N. Li, G. Taffet, and N. G. Frangogiannis Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial Infarction J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1384 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N. G. Frangogiannis CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response J. Immunol., February 15, 2008; 180(4): 2625 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bujak, G. Ren, H. J. Kweon, M. Dobaczewski, A. Reddy, G. Taffet, X.-F. Wang, and N. G. Frangogiannis Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling Circulation, November 6, 2007; 116(19): 2127 - 2138. [Abstract] [Full Text] [PDF]
|
|